X

Vous n'êtes pas connecté

Rubriques :

  - ZACKS.COM - All Stories - 07/Aug 12:35

Xeris Biopharma (XERS) Reports Q2 Loss, Tops Revenue Estimates

Xeris Biopharma (XERS) delivered earnings and revenue surprises of +66.67% and +10.06%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Articles similaires

Sorry! Image not available at this time

Xeris Biopharma (XERS) Reports Q2 Loss, Tops Revenue Estimates

zacks.com - 07/Aug 12:35

Xeris Biopharma (XERS) delivered earnings and revenue surprises of +66.67% and +10.06%, respectively, for the quarter ended June 2025. Do the numbers...

Sorry! Image not available at this time

LifeStance Health Group (LFST) Reports Q2 Loss, Tops Revenue Estimates

zacks.com - 07/Aug 11:15

LifeStance Health (LFST) delivered earnings and revenue surprises of +66.67% and +0.02%, respectively, for the quarter ended June 2025. Do the numbers...

Sorry! Image not available at this time

LifeStance Health Group (LFST) Reports Q2 Loss, Tops Revenue Estimates

zacks.com - 07/Aug 11:15

LifeStance Health (LFST) delivered earnings and revenue surprises of +66.67% and +0.02%, respectively, for the quarter ended June 2025. Do the numbers...

Sorry! Image not available at this time

Aspen Aerogels (ASPN) Reports Q2 Loss, Tops Revenue Estimates

zacks.com - 07/Aug 11:40

Aspen Aerogels (ASPN) delivered earnings and revenue surprises of +66.67% and +8.26%, respectively, for the quarter ended June 2025. Do the numbers...

Sorry! Image not available at this time

Cue Biopharma, Inc. (CUE) Reports Q2 Loss, Tops Revenue Estimates

zacks.com - 12/Aug 21:10

Cue Biopharma (CUE) delivered earnings and revenue surprises of +30.77% and +47.70%, respectively, for the quarter ended June 2025. Do the numbers...

Sorry! Image not available at this time

Cue Biopharma, Inc. (CUE) Reports Q2 Loss, Tops Revenue Estimates

zacks.com - 12/Aug 21:10

Cue Biopharma (CUE) delivered earnings and revenue surprises of +30.77% and +47.70%, respectively, for the quarter ended June 2025. Do the numbers...

Sorry! Image not available at this time

Theravance Biopharma (TBPH) Reports Q2 Loss, Tops Revenue Estimates

zacks.com - 12/Aug 21:25

Theravance Bio (TBPH) delivered earnings and revenue surprises of +42.86% and +53.76%, respectively, for the quarter ended June 2025. Do the numbers...

Sorry! Image not available at this time

Theravance Biopharma (TBPH) Reports Q2 Loss, Tops Revenue Estimates

zacks.com - 12/Aug 21:25

Theravance Bio (TBPH) delivered earnings and revenue surprises of +42.86% and +53.76%, respectively, for the quarter ended June 2025. Do the numbers...

Sorry! Image not available at this time

Sweetgreen, Inc. (SG) Reports Q2 Loss, Lags Revenue Estimates

zacks.com - 07/Aug 22:05

Sweetgreen (SG) delivered earnings and revenue surprises of -66.67% and -3.11%, respectively, for the quarter ended June 2025. Do the numbers hold...

Sorry! Image not available at this time

Sutro Biopharma, Inc. (STRO) Reports Q2 Loss, Beats Revenue Estimates

zacks.com - 07/Aug 21:50

Sutro Biopharma (STRO) delivered earnings and revenue surprises of +64.10% and +293.54%, respectively, for the quarter ended June 2025. Do the numbers...

Les derniers communiqués